The device was returned to the resmed design house located in (b)(6) for an extensive engineering investigation.A preliminary evaluation of the device data was performed and determined that there was no indication of an error leading to the device stopping therapy.Based on available evidence at this time, there is no indication that a device malfunction contributed to the reported event.The investigation methods, results, and conclusion are not finalized at this stage.The risk has been reviewed and deemed to be acceptable in the risk analysis document.Resmed reference #: (b)(4).
|